Km. Stenson et al., The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy - The feasibility of selective neck dissection, ARCH OTOLAR, 126(8), 2000, pp. 950-956
Objectives: To evaluate the necessity, technical feasibility, and complicat
ion rate of neck dissection performed on patients with head and neck cancer
after 5 cycles of concomitant chemoradiotherapy (CRT) and to justify a sel
ective neck dissection (SND) approach and define the optimal timing of post
-CRT neck dissection.
Design and Setting: Retrospective analysis in an academic university medica
l center.
Patients: Sixty-nine eligible patients with advanced (stage III and IV) hea
d and neck cancer who have undergone 1 of 4 CRT protocols. Patients ranged
in age from 36 to 75 years, and surgical procedures were performed over a 4
-year period. Follow-up ranged from 6 to 64 months.
Intervention: Neck dissection (most commonly unilateral SND) performed with
in 5 to 17 weeks after CRT completion.
Main Outcome Measures: Complication rate and incidence of positive patholog
y (viable cancer) in pathologic neck dissection specimens.
Results: Seven (10%) of 69 patients developed wound healing complications,
4 (6%) of whom required surgical intervention for ultimate closure. There w
ere no wound infections. Other complications occurred in 11 (16%) of 69 pat
ients and included need for tracheotomy, nerve transection and paresis, and
permanent hypocalcemia. Twenty-four (35%) of 69 patients revealed microsco
pic residual disease. Ten (50%) of 20 patients with N3 neck disease had pos
itive pathology, whereas 14 (36%) of 39 patients with N2 disease had viable
carcinoma in the dissection specimen (P=.09 by chi(2) analysis). There was
no significant relation between radiologic complete response or partial re
sponse and residual microscopic cancer. In 1 patient, disease recurred in t
he neck after dissection. Mean follow-up time was 30.3 months.
Conclusions: (1) Neck dissection for patients with N2 or greater neck disea
se after CRT is necessary to eradicate residual disease. (2) The complicati
on rate of SND after CRT with hyperfractionated radiotherapy is low. (3) SN
Ds are technically feasible when performed within the "window" between the
acute and chronic CRT injury (4-12 weeks). (4) SNDs, rather than more radic
al procedures, appear to be therapeutically appropriate in this group of pa
tients because of the low incidence of disease recurrence in the neck.